AbbVie
ABBV
#28
Rank
C$425.09 B
Marketcap
$240.30
Share price
2.13%
Change (1 day)
4.47%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2024 (TTM): C$4.87 Billion

According to AbbVie's latest financial reports the company's current earnings are C$56.33 Billion. a decrease over its 2023 earnings that were of C$8.64 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2024

Annual earnings

Year Earnings Change
2024 C$5.13 B-40.54%
2023 C$8.64 B-53.62%
2022 C$18.63 B3.76%
2021 C$17.96 B282.25%
2020 C$4.69 B-59.67%
2019 C$11.65 B62.13%
2018 C$7.18 B-32.74%
2017 C$10.68 B-1.99%
2016 C$10.90 B18.65%
2015 C$9.18 B180.5%
2014 C$3.27 B-55.57%
2013 C$7.37 B-6.86%
2012 C$7.91 B56.05%
2011 C$5.07 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$15.36 B 199.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$11.59 Billion-325.48%๐Ÿ‡บ๐Ÿ‡ธ USA
C$17.53 B 241.24%๐Ÿ‡บ๐Ÿ‡ธ USA
C$6.37 B 24.03%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.95 B-81.43%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.63 B-48.71%๐Ÿ‡บ๐Ÿ‡ธ USA
C$6.07 B 18.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$14.42 B 180.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$0.70 B-86.19%๐Ÿ‡บ๐Ÿ‡ธ USA